Churchill Capital X director granted 29,950 options

Churchill Capital Corp X/Cayman director James Eric Bjornholt reported an option grant.

Accepted by SEC EDGAR 02/18/2026 - 08:52 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Churchill Capital Corp X/Cayman director James Eric Bjornholt reported an option grant. He acquired a stock option covering 29,950 shares of the company’s stock. According to the vesting terms, one-third of the option vests on February 17, 2027, and the remaining shares vest in equal monthly installments over the following three years, conditioned on his continued service.

Insider Trade Summary

Grant/Award: 29,950 shares

Grant/Award 1 txn

Insider Bjornholt James Eric

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	29,950	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 29,950 contracts (Direct)

Footnotes (1)

1. F1. 1/3rd of the shares underlying the option shall vest on February 17, 2027, and 1/36th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Churchill Capital Corp X (CCCX) disclose in this Form 4?

Churchill Capital Corp X reported a director, James Eric Bjornholt, receiving a stock option grant for 29,950 shares. The filing details the size of the award and its multi-year vesting schedule tied to his continued service with the company.

How many shares are covered by James Eric Bjornholt’s option grant at CCCX?

The reported stock option grant to James Eric Bjornholt covers 29,950 shares. This number represents the total shares underlying the option, which will vest over time rather than all at once, subject to his ongoing service to Churchill Capital Corp X.

What is the vesting schedule for the Churchill Capital Corp X director’s option grant?

One-third of the option shares vest on February 17, 2027. The remaining two-thirds vest in 1/36th increments each month thereafter on the same calendar day, contingent on James Eric Bjornholt continuing to serve the company through each vesting date.

Who is the insider involved in this Churchill Capital Corp X (CCCX) Form 4?

The insider is James Eric Bjornholt, identified as a director of Churchill Capital Corp X. The Form 4 reports his acquisition of a stock option award, documenting the number of underlying shares and the detailed vesting terms attached to this equity grant.

Does the Churchill Capital Corp X Form 4 show a stock purchase or just an option grant?

The Form 4 shows an option grant, not an open-market stock purchase. It records the award of a derivative security, specifically a stock option over 29,950 shares, which will vest over time based on continued service with Churchill Capital Corp X.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bjornholt James Eric

(Last) (First) (Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE CO 80027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Churchill Capital Corp X/Cayman [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$13.22	02/13/2026		A		29,950		(1)	02/12/2036	Common Stock	29,950	$0	29,950	D

Explanation of Responses:

1. 1/3rd of the shares underlying the option shall vest on February 17, 2027, and 1/36th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

	/s/ Jason D. Hall, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.